Prelude Therapeutics (PRLD) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Prelude Therapeutics

    NASDAQ: PRLD · Real-Time Price · USD
    1.47
    0.03 (2.08%)
    At close: Oct 03, 2025, 3:59 PM
    1.47
    0.00%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Prelude Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 12.47M 25.29M 30.61M 31.83M
    Short-Term Investments
    		 121.14M 207.64M 171.12M 259.4M
    Long-Term Investments
    		 n/a n/a 4.04M 4.04M
    Other Long-Term Assets
    		 4.15M 4.34M 5.38M 303K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 2.28M 2.65M 2.65M 3.88M
    Total Current Assets
    		 135.9M 235.59M 204.38M 295.12M
    Property-Plant & Equipment
    		 35.47M 37.74M 6.7M 5.64M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 39.62M 42.08M 16.12M 9.98M
    Total Assets
    		 175.51M 277.67M 220.5M 305.1M
    Account Payables
    		 7.73M 4.58M 6.78M 7.84M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 2.7M n/a 1.83M 1.74M
    Other Current Liabilities
    		 7.09M 6.61M 5.58M 3.27M
    Total Current Liabilities
    		 25.64M 21.83M 21.7M 19.2M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 3.09M 3.34M 3.36M n/a
    Total Long-Term Liabilities
    		 18.41M 18.75M 3.36M n/a
    Total Liabilities
    		 44.06M 40.58M 25.06M 19.2M
    Total Debt
    		 18.02M 16.89M 1.83M 1.74M
    Book Value
    		 131.46M 237.09M 195.44M 285.9M
    Book Value Per Share
    		 1.73 3.93 4.13 6.01
    Common Stock
    		 4K 5K 5K 5K
    Retained Earnings
    		 -583.56M -456.39M -334.56M -219.12M
    Comprehensive Income
    		 35K 223K -1.69M -711K
    Shareholders Equity
    		 131.46M 237.09M 195.44M 285.9M
    Total Investments
    		 121.14M 207.64M 171.12M 259.4M

    Add to Watchlist